Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Hanna Sandberg-Gertzén"'
Autor:
Maria Elmberg, Johan Askling, Sigvard Olsson, Stefan Lindgren, Rolf Hultcrantz, Fereshte Ebrahim, Lars Lööf, Anders Ekbom, Per Stål, Sven Almer, Hanna Sandberg-Gertzén, Sven Wallerstedt
Publikováno v:
Gastroenterology. 137:1301-1309
Background & Aims Hereditary hemochromatosis (HH) is an autosomal-recessive disorder characterized by iron overload. Relatives of HH patients were screened and those with HH-associated mutations and an increased iron load were identified. However, li
Autor:
Mårten Werner, Per Sangfelt, Ola Weiland, Sven Almer, Hanne Prytz, Hanna Sandberg-Gertzén, Åke Danielsson, Einar Björnsson, Stefan Lindgren, Sven Wallerstedt, Annika Bergquist, Rolf Hultcrantz
Publikováno v:
Journal of Hepatology. 50:388-393
Autoimmune Hepatitis (AIH) is a liver disease which may lead to liver cirrhosis. Cirrhosis is a well-known risk factor for hepatocellular cancer. Lymphoma is a disease, where immune modulating drugs as well as the autoimmune disease itself may contri
Autor:
Curt Tysk, Jonas Halfvarson, Gunnar Järnerot, Anders Gustavsson, Hanna Sandberg-Gertzén, Anders Magnuson
Publikováno v:
The American Journal of Gastroenterology. 102:2513-2519
Corticosteroids are a cornerstone in the treatment of a severe attack of ulcerative colitis (UC). The long-term prognosis in this patient group is not well described. We studied the long-term colectomy and relapse rates in patients given intensive in
Autor:
Hanna Sandberg-Gertzén, Magnus Ström, Björn Blomberg, Bengt Curman, Henrik Hjortswang, Curt Tysk, Sven Almer, Gunnar Järnerot
Publikováno v:
European Journal of Gastroenterology & Hepatology. 15:1011-1020
The importance of a patient's experience of disease impact on daily life and well-being (health-related quality of life (HRQOL)) is broadly acknowledged. Scepticism still remains about how HRQOL should be measured and the usefulness of standardised H
Autor:
Åke Danielsson, S Wallerstedt, Hanna Sandberg-Gertzén, Rolf Hultcrantz, R Olson, Lars Lööf, F Depner, R Wassmuth, Hanne Prytz, S Lindgren
Publikováno v:
Tissue Antigens. 59:381-387
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis.
Publikováno v:
Baillière's Clinical Gastroenterology. 12:73-92
Active Crohn's disease constitutes a major problem in gastroenterology. Symptoms vary with site, extent and local complications of the disease as well as with the absence or presence of extraintestinal manifestations. Due to the troublesome consequen
Autor:
Staffan Wahlin, Rolf Hultcrantz, Magnus Simrén, Sven Almer, Hanne Prytz, Klas Sjöberg, Sven Wallerstedt, Lars Lööf, Hanna Sandberg Gertzén, Anders Odén
Publikováno v:
Scandinavian Journal of Gastroenterology
Objective. Development of ascites in patients with liver cirrhosis is an ominous sign with a poor outcome. A liver transplantation must be considered, and it then becomes important to know if there are any factors indicating a worsened prognosis. Mat
Autor:
Stefan Lindgren, Bengt-Olof Rydén, Lars Lööf, Hanna Sandberg-Gertzén, Rolf Olsson, Sven Wallerstedt, Åke Danielsson, Rolf Hultcrantz, Hans-Olov Adami, Ljusk Siw Eriksson, Hanne Prytz, Pär Sparén
Publikováno v:
Hepatology. 20:101-104
A cohort of 559 patients in Sweden who satisfied predetermined criteria for the diagnosis of primary biliary cirrhosis was followed with respect to the incidence of cancer during the period of 1958 to 1988. The mean follow-up time from the time of pr
Autor:
M. Gangsoy-Kristiansen, Åke Danielsson, Rolf Hultcrantz, Hanne Prytz, Per Sangfelt, Hanna Sandberg-Gertzén, G. Folvik, Kirsten Muri Boberg, Andreas Rydning, Ingalill Friis-Liby, Annika Bergquist, Ola Wikman, Lina Lindström
Publikováno v:
Alimentary pharmacologytherapeutics. 35(4)
Background Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) have a high risk of developing colorectal cancer and dysplasia. Ursodeoxycholic acid (UDCA) has been suggested to have chemopreventive effects on the d
Autor:
Åke Danielsson, Rolf Hultcrantz, Per Stål, Sanam Endalib, Sven Wallerstedt, Lars Lööf, Sigvard Olsson, Sven Almer, Soo Aleman, Stefan Lindgren, Hanna Sandberg-Gertzén
Publikováno v:
Scandinavian Journal of Gastroenterology; 46(9), pp 1118-1126 (2011)
Objective. The information concerning the morbidity and mortality of hereditary hemochromatosis is based primarily on clinical cohorts of symptomatic patients. The major aim of this study was to analyze the long-term prognosis for Swedish patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ac857ae26b6989b457f8730063699e
https://lup.lub.lu.se/record/2162283
https://lup.lub.lu.se/record/2162283